Skip to Main Content

Author Details

Raveen Rathnasinghe
Icahn School of Medicine at Mount Sinai New York
2015
42
18
Kirsten Obernier (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36711479A multicomponent intranasal adjuvant drives durable humoral, cellular, and mucosal immune responses to SARS-CoV-2 in young and aged mice.Res Sq2023
37794051Self-amplifying mRNA seasonal influenza vaccines elicit mouse neutralizing antibody and cell-mediated immunity and protect ferrets.NPJ Vaccines2023
37581936Rescue of alveolar wall liquid secretion blocks fatal lung injury due to influenza-staphylococcal coinfection.J Clin Invest2023
37738983Impact of SARS-CoV-2 ORF6 and its variant polymorphisms on host responses and viral pathogenesis.Cell Host Microbe2023
37600776Influenza breakthrough infection in vaccinated mice is characterized by non-pathological lung eosinophilia.Front Immunol2023
37386041Multicomponent intranasal adjuvant for mucosal and durable systemic SARS-CoV-2 immunity in young and aged mice.NPJ Vaccines2023
35169796The oral drug nitazoxanide restricts SARS-CoV-2 infection and attenuates disease pathogenesis in Syrian hamsters.bioRxiv2022
36426358RIG-I and TLR-7/8 agonists as combination adjuvant shapes unique antibody and cellular vaccine responses to seasonal influenza vaccine.Front Immunol2022
36044897Discovery and intranasal administration of a SARS-CoV-2 broadly acting neutralizing antibody with activity against multiple Omicron subvariants.Med2022
35128980Modeling SARS-CoV-2: Comparative Pathology in Rhesus Macaque and Golden Syrian Hamster Models.Toxicol Pathol2022
35247306Limited extent and consequences of pancreatic SARS-CoV-2 infection.Cell Rep2022
35150638Mutations in SARS-CoV-2 variants of concern link to increased spike cleavage and virus transmission.Cell Host Microbe2022
33464672Sterilizing Immunity against SARS-CoV-2 Infection in Mice by a Single-Shot and Lipid Amphiphile Imidazoquinoline TLR7/8 Agonist-Adjuvanted Recombinant Spike Protein Vaccine*.Angew Chem Int Ed Engl2021
33495306Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A.Science2021
33653892Introduction of Two Prolines and Removal of the Polybasic Cleavage Site Lead to Higher Efficacy of a Recombinant Spike-Based SARS-CoV-2 Vaccine in the Mouse Model.mBio2021
33619480A Combination Adjuvant for the Induction of Potent Antiviral Immune Responses for a Recombinant SARS-CoV-2 Protein Vaccine.bioRxiv2021
33619476COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical models.Res Sq2021
33920517Replication-Competent οNS1 Influenza A Viruses Expressing Reporter Genes.Viruses2021
33532796The E484K mutation in the SARS-CoV-2 spike protein reduces but does not abolish neutralizing activity of human convalescent and post-vaccination sera.medRxiv2021
33836156TOP1 inhibition therapy protects against SARS-CoV-2-induced lethal inflammation.Cell2021
33501468The N501Y mutation in SARS-CoV-2 spike leads to morbidity in obese and aged mice and is neutralized by convalescent and post-vaccination human sera.medRxiv2021
34707161A Newcastle disease virus expressing a stabilized spike protein of SARS-CoV-2 induces protective immune responses.Nat Commun2021
34671037COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical models.Nat Commun2021
34401874Prophylactic Protection Against Respiratory Viruses Conferred by a Prototype Live Attenuated Influenza Virus Vaccine.Res Sq2021
34603303A Combination Adjuvant for the Induction of Potent Antiviral Immune Responses for a Recombinant SARS-CoV-2 Protein Vaccine.Front Immunol2021
34773048Interferon mediated prophylactic protection against respiratory viruses conferred by a prototype live attenuated influenza virus vaccine lacking non-structural protein 1.Sci Rep2021
34620951Scalable, effective, and rapid decontamination of SARS-CoV-2 contaminated N95 respirators using germicidal ultraviolet C (UVC) irradiation device.Sci Rep2021
34593848The virucidal effects of 405 nm visible light on SARS-CoV-2 and influenza A virus.Sci Rep2021
34326236Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2.Science2021
33948589Prophylactic protection against respiratory viruses conferred by a prototype live attenuated influenza virus vaccine.bioRxiv2021
34278670Corrigendum: Sterilizing Immunity against SARS-CoV-2 Infection in Mice by a Single-Shot and Lipid Amphiphile Imidazoquinoline TLR7/8 Agonist-Adjuvanted Recombinant Spike Protein Vaccine.Angew Chem Int Ed Engl2021
32546784Author Correction: Microbiome disturbance and resilience dynamics of the upper respiratory tract during influenza A virus infection.Nat Commun2020
33052360Scalable, effective, and rapid decontamination of SARS-CoV-2 contaminated N95 respirators using germicidal ultra-violet C (UVC) irradiation device.medRxiv2020
33073694Comparison of transgenic and adenovirus hACE2 mouse models for SARS-CoV-2 infection.Emerg Microbes Infect2020
33299999Topoisomerase 1 inhibition therapy protects against SARS-CoV-2-induced inflammation and death in animal models.bioRxiv2020
33097660SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling.Proc Natl Acad Sci U S A2020
32995785Introduction of two prolines and removal of the polybasic cleavage site leads to optimal efficacy of a recombinant spike based SARS-CoV-2 vaccine in the mouse model.bioRxiv2020
32707573Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing.Nature2020
32676603Comparison of Transgenic and Adenovirus hACE2 Mouse Models for SARS-CoV-2 Infection.bioRxiv2020
32439901Microbiome disturbance and resilience dynamics of the upper respiratory tract during influenza A virus infection.Nat Commun2020
30054993Reemergence of H3N8 Equine Influenza A virus in Chile, 2018.Transbound Emerg Dis2018
25056421A new method to pair-match metacarpals using bilateral asymmetry and shape analysis.J Forensic Sci2015
  • 1 - 42 of 42

Recommended Authors

Tianyang Mao
Yale University School of Medicine
Career Start Year 2017
Number of shared co-authors 0
James Logue
Center for Pathogen Research, University of Maryland School of Medicine
Career Start Year 2017
Number of shared co-authors 20
Alexander S Jureka
University of Alabama at Birmingham
Career Start Year 2015
Number of shared co-authors 24
Sarah R Leist
University of North Carolina at Chapel Hill
Career Start Year 2014
Number of shared co-authors 5
Hongjie Xia
University of Texas Medical Branch
Career Start Year 2012
Number of shared co-authors 2
Brook E Heaton
Duke University School of Medicine
Career Start Year 2012
Number of shared co-authors 3
Meagan E Deming
University of Maryland School of Medicine
Career Start Year 2011
Number of shared co-authors 2
Shashank Tripathi
Indian Institute of Science
Career Start Year 2011
Number of shared co-authors 30
Kenneth S Plante
University of Texas Medical Branch
Career Start Year 2009
Number of shared co-authors 2
Vineet D Menachery
University of Texas Medical Branch
Career Start Year 2008
Number of shared co-authors 2
Hans-Heinrich Hoffmann
The Rockefeller University
Career Start Year 2008
Number of shared co-authors 8
Mila B Ortigoza
NYU Grossman School of Medicine
Career Start Year 2006
Number of shared co-authors 5
Nicholas S Heaton
Duke University School of Medicine
Career Start Year 2006
Number of shared co-authors 16
Melissa M Coughlin
Centers for Disease Control and Prevention
Career Start Year 2006
Number of shared co-authors 0
Sudhakar Agnihothram
National Center for Toxicological Research
Career Start Year 2005
Number of shared co-authors 1
Emmie de Wit
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 2004
Number of shared co-authors 20
Alexandra Sch??fer
University of North Carolina at Chapel Hill
Career Start Year 2003
Number of shared co-authors 5
Natalie J Thornburg
Centers for Disease Control and Prevention (CDC)
Career Start Year 2003
Number of shared co-authors 5
Balaji Manicassamy
University of Iowa
Career Start Year 2002
Number of shared co-authors 23
Lisa E Gralinski
University of North Carolina at Chapel Hill
Career Start Year 2002
Number of shared co-authors 2
Kayvon Modjarrad
Center for Infectious Diseases Research, Walter Reed Army Institute of Research
Career Start Year 2002
Number of shared co-authors 0
Man-Seong Park
Korea University College of Medicine
Career Start Year 2001
Number of shared co-authors 8
Timothy H Burgess
Infectious Disease Clinical Research Program, Uniformed Services University
Career Start Year 2000
Number of shared co-authors 0
Gary P Kobinger
University of Texas Medical Branch
Career Start Year 1997
Number of shared co-authors 4
Matthew B Frieman
Center for Pathogen Research, University of Maryland School of Medicine
Career Start Year 1993
Number of shared co-authors 34
Boyd L Yount
University of North Carolina at Chapel Hill
Career Start Year 1993
Number of shared co-authors 4
Ted M Ross
Center for Vaccines and Immunology, University of Georgia
Career Start Year 1991
Number of shared co-authors 6
Chien-Te K Tseng
The University of Texas Medical Branch
Career Start Year 1991
Number of shared co-authors 1
Bart L Haagmans
Erasmus Medical Center
Career Start Year 1986
Number of shared co-authors 2
Ralph S Baric
University of North Carolina
Career Start Year 1981
Number of shared co-authors 10

Collaborators

Michael Schotsaert
Icahn School of Medicine at Mount Sinai
Co-authored papers 35
Adolfo Garc??a-Sastre
Icahn School of Medicine at Mount Sinai
Co-authored papers 34
Ignacio Mena
Icahn School of Medicine at Mount Sinai
Co-authored papers 11
Lynda Coughlan
University of Maryland
Co-authored papers 11
Soner Yildiz
University of Geneva
Co-authored papers 8
Lisa Miorin
Icahn School of Medicine at Mount Sinai
Co-authored papers 8
Randy A Albrecht
Icahn School of Medicine at Mount Sinai
Co-authored papers 7
Kris M White
Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG)
Co-authored papers 7
Viviana Simon
Icahn School of Medicine at Mount Sinai
Co-authored papers 5
Teresa Aydillo
Icahn School of Medicine at Mount Sinai
Co-authored papers 5
Nevan J Krogan (CM4AI)
University of California San Francisco
Co-authored papers 5
Peter Palese
Icahn School of Medicine at Mount Sinai
Co-authored papers 4
Sumit K Chanda
The Scripps Research Institute
Co-authored papers 4
David A Meekins
College of Veterinary Medicine, Kansas State University
Co-authored papers 4
Luis Martinez-Sobrido
Texas Biomedical Research Institute
Co-authored papers 4
Harm van Bakel
Icahn School of Medicine at Mount Sinai
Co-authored papers 4
Melissa B Uccellini
Icahn School of Medicine at Mount Sinaigrid.59734.3c
Co-authored papers 4
Marion Dejosez
Icahn School of Medicine at Mount Sinai
Co-authored papers 4
Thomas P Zwaka
Icahn School of Medicine at Mount Sinai
Co-authored papers 4
Juergen A Richt
College of Veterinary Medicine, Kansas State University
Co-authored papers 4
Phillip Cohen
Icahn School of Medicine at Mount Sinai
Co-authored papers 3
Mehdi Bouhaddou
J. David Gladstone Institutes
Co-authored papers 3
Christopher Benner
Michigan State University College of Human Medicine
Co-authored papers 3
Emilia Mia Sordillo
Icahn School of Medicine at Mount Sinai
Co-authored papers 3
Carles Mart??nez-Romero
Icahn School of Medicine at Mount Sinai
Co-authored papers 3
Laura Martin-Sancho
The Scripps Research Institute
Co-authored papers 2
Sven Heinz
U.C. San Diego School of Medicine
Co-authored papers 2
Manon Laporte
Rega Institute
Co-authored papers 2
Chengjin Ye
Texas Biomedical Research Institute
Co-authored papers 2
Ivan Marazzi
Center for Epigenetics and Metabolism, University of California irvine
Co-authored papers 2
Release 1.2